Tina Hartert

A clinical trial supports approval of a new medication to treat moderate-to-severe asthma in children.
April 24, 2023

Study finds early RSV infection linked to significantly increased risk of asthma in children

A Vanderbilt study has found that RSV infection in the first year of life is associated with a significantly increased risk of asthma in children.

By Nancy Humphrey
April 4, 2023

Vanderbilt receives $1 million in funding for electric vehicle research

Vanderbilt has received funding for two projects that will examine the benefits of and barriers to widespread use of electric vehicles and potential public health impacts of EV adoption.

By VUMC News and Communications
March 9, 2023

Study finds RSV may evade vaccines via rapid mutation

A Vanderbilt study concluded that RSV’s ability to mutate rapidly to escape detection by the body’s immune system makes it more challenging to design and develop vaccines that can stop it from spreading.

By Bill Snyder
A clinical trial supports approval of a new medication to treat moderate-to-severe asthma in children.
July 21, 2022

Study explores role RSV plays in later asthma development

A Vanderbilt clinical project will follow 1,950 Middle Tennessee children to determine how genes and the environment interact with RSV infection during the first year of life and contribute to asthma development

By Leah Mann
June 3, 2022

Food allergy linked to lower risk of SARS-CoV-2 infection

By Nancy Humphrey
May 12, 2020

Study to determine rate of novel coronavirus infection in U.S. children

Researchers at Vanderbilt University Medical Center (VUMC) are leading a nationwide study to determine the rate of novel coronavirus infection in U.S. children and their families.

By Kelsey Herbers
July 12, 2018

Team explores diabetes drug’s ability to treat RSV infection

A drug used to treat diabetes may point to new therapies for respiratory syncytial virus (RSV) bronchiolitis — inflammation and obstruction of the lungs’ small airways. A multi-disciplinary team of Vanderbilt investigators has demonstrated that liraglutide reduces the inflammatory response to RSV infection in a mouse model of the disease.
By Leigh MacMillan
May 15, 2017

RSV-HRV viral interference

RSV infection reduces the risk of infection with human rhinovirus, which could have implications for vaccine development and prevention strategies for viral respiratory tract infections in infants.
By Leigh MacMillan
September 29, 2016

Childhood health influences focus of new NIH initiative

The National Institutes of Health (NIH) recently announced it will provide $157 million in awards to launch a multi-center, seven-year initiative that will investigate how exposure to environmental factors in early development — from conception through early childhood — influences the health of children and adolescents.
By Kathy Whitney
July 21, 2016

Team to study RSV’s role in asthma formation

Investigators in the Division of Allergy, Pulmonary and Critical Care Medicine recently received a $4.5 million Asthma and Allergic Diseases Cooperative Research Center (AADCRC) grant from the National Institutes of Allergy and Infectious Diseases (NIAID).
By VUMC News and Communications
May 12, 2016

Medical societies honor four VUMC physicians

Four physicians from Vanderbilt University Medical Center (VUMC) have been elected to membership in two of the nation’s oldest and most respected medical honor societies — the Association of American Physicians (AAP) and the American Society for Clinical Investigation (ASCI).
By Bill Snyder
November 5, 2015

New awards honor contributions to translational research at VUMC

Two physician-scientist leaders at Vanderbilt University Medical Center were honored last week with newly created awards for helping to build and nurture Vanderbilt’s vibrant culture of clinical and translational research.
By Bill Snyder
January 30, 2014

Hartert to help lead Translational Science efforts

Tina Hartert, M.D., MPH, professor of Medicine in the Division of Allergy, Pulmonary and Critical Care Medicine, has been named assistant vice chancellor for Translational Science.
By Kathy Whitney
1 2